HGR 19.88 Hanger Orthopedic Group $HGR Hit a 52 week low of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 10:36 AM

HGR 19.88 Hanger Orthopedic Group $HGR Hit a 52 week low of 19.59 Currently at 19.88 -4.31 -17.82% With a day low of 19.59 and a total volume of 1,484,400.

HGR Hanger Orthopedic Group Recent Headline News

NYSE stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
PNK: 22.85 (-0.37), CZZ: 9.42 (+0.08), PBH: 32.79 (-4.53), TCAP: 23.47 (+0.96), MED: 29.77 (-3.04), AMBR: 11.40 (-2.21), ANF: 29.50 (-5.88), NSM: 29.83 (+1.96), NKA: 5.41 (-0.54), GNW: 8.41 (-0.25), HGR: 19.88 (-4.31), KOP: 32.47 (+0.25)

Hanger to Reschedule Third Quarter 2014 Earnings Release and Conference Call
PR Newswire - Thu Nov 06, 3:12PM CST
Hanger, Inc. (NYSE: HGR) announced today that it is rescheduling the release of its third quarter 2014 earnings and related earnings conference call to allow additional time for the completion and review of its third quarter financial statements. The Company expects to reschedule the call to occur the week of November 10th, and will issue a press release with the specific date prior to the event.
HGR: 19.88 (-4.31)

Hanger Orthopedic Down 29.2% Since SmarTrend Downtrend Call (HGR)
Comtex SmarTrend(R) - Tue Nov 04, 9:15AM CST
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 8 months, Hanger Orthopedic has returned 29.21% as of today's recent price of $23.74.
HGR: 19.88 (-4.31)

Hanger Orthopedic Down 33.1% Since SmarTrend Downtrend Call (HGR)
Comtex SmarTrend(R) - Mon Oct 27, 4:50PM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 7 months, Hanger Orthopedic has returned 33.11% as of today's recent price of $22.43.
HGR: 19.88 (-4.31)

34.3% Return Seen to Date on SmarTrend Hanger Orthopedic Call (HGR)
Comtex SmarTrend(R) - Mon Oct 20, 11:01AM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 7 months, Hanger Orthopedic has returned 34.34% as of today's recent price of $22.02.
HGR: 19.88 (-4.31)

Hanger to Release Third Quarter 2014 Results on Thursday, November 6 After Market Close and Host Conference Call at 9:00 am Eastern on Friday, November 7
PR Newswire - Fri Oct 17, 4:00PM CDT
Hanger, Inc. (NYSE: HGR) announced today that it plans to report its results of operations for the quarter ended September 30, 2014, on Thursday, November 6, 2014 after the market closes. A conference call to discuss these results is scheduled to begin at 9:00 a.m., ET, on Friday, November 7, 2014. Those wishing to participate should call 1-877-662-6095. A replay will be available until Friday, November 14, 2014 by dialing 1-855-859-2056 and referencing Conference ID # 91880739.
HGR: 19.88 (-4.31)

Hanger Orthopedic Has Returned 37.8% Since SmarTrend Recommendation (HGR)
Comtex SmarTrend(R) - Mon Oct 13, 9:30AM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 7 months, Hanger Orthopedic has returned 37.80% as of today's recent price of $20.86.
HGR: 19.88 (-4.31)

Hanger Underperforms on Falling Earnings and Guidance - Analyst Blog
Souvik Guha - Zacks Investment Research - Mon Sep 29, 12:50PM CDT
Hanger (HGR) posted first-quarter adjusted earnings of 19 cents per share, down 29.6% from the year-ago level of 27 cents.
ICUI: 71.16 (-0.89), SMA: 9.27 (-0.21), HGR: 19.88 (-4.31), HSP: 56.32 (-0.32)

Downtrend Call Working As Hanger Orthopedic Stock Falls 37.4% (HGR)
Comtex SmarTrend(R) - Fri Sep 26, 4:45PM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 6 months, Hanger Orthopedic has returned 37.44% as of today's recent price of $20.98.
HGR: 19.88 (-4.31)

Hanger Orthopedic Shares Down 33.2% Since SmarTrend's Sell Call (HGR)
Comtex SmarTrend(R) - Fri Sep 19, 11:01AM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 6 months, Hanger Orthopedic has returned 33.17% as of today's recent price of $22.41.
HGR: 19.88 (-4.31)

Hanger announces Thomas Kiraly to become Chief Financial Officer
PR Newswire - Thu Sep 11, 3:10PM CDT
Hanger, Inc. (NYSE: HGR) today announced that Thomas Kiraly, former Executive Vice President, Chief Financial Officer, and Treasurer of Sheridan Healthcare, will join Hanger as Executive Vice President on Oct. 1 and will become Chief Financial Officer during the fourth quarter 2014. Mr. Kiraly will work closely with incumbent CFO George McHenry until Mr. Kiraly assumes the role of CFO later this year. As previously announced, Mr. McHenry will retire on Dec. 31, 2014.
HGR: 19.88 (-4.31)

Hanger Appoints Melissa Debes as Chief Accounting Officer
PR Newswire - Wed Sep 03, 3:05PM CDT
Hanger, Inc. (NYSE: HGR) today announced it has appointed Melissa Debes as Vice President and Chief Accounting Officer, effective September 8, 2014. Ms. Debes has served as Corporate Controller at Hanger since March 11, 2014.
HGR: 19.88 (-4.31)

Insider Trading Alert - RSG, HGR And URI Traded By Insiders
at The Street - Wed Aug 27, 9:30AM CDT
Stocks with insider trader activity include RSG, HGR and URI
RSG: 39.13 (+0.42), HGR: 19.88 (-4.31), URI: 113.39 (-0.37)

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
ABMD: 32.13 (+0.47), BDX: 125.54 (-2.39), MDT: 68.10 (-0.64), ARAY: 6.85 (-0.05), NUVA: 41.75 (-0.18), CYBX: 50.30 (-0.90), BSX: 13.24 (-0.12), JNJ: 108.20 (-0.81), ICUI: 71.16 (-0.89), WMGI: 27.95 (-0.49), OPK: 8.32 (-0.10), RMD: 51.14 (-0.43), ABBV: 61.50 (-1.21), SYK: 87.47 (-1.08), ZMH: 108.19 (-2.00), ABT: 43.37 (-0.32), SMA: 9.27 (-0.21), BCR: 162.38 (-2.59), MCK: 199.32 (-3.34), TMO: 116.60 (-2.31), PFE: 29.92 (-0.12), COV: 92.08 (-0.52), EW: 122.76 (-0.81), MYL: 53.11 (-0.39), COO: 165.00 (-1.08), CG: 28.94 (+0.68), ABAX: 51.63 (-2.21), BAX: 70.61 (-0.99), DGX: 61.69 (-1.07), STJ: 64.76 (-1.28), THOR: 26.93 (+0.83), HGR: 19.88 (-4.31)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quanta Services Reports Record Q3 2026 Earnings

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Faith on Trial: La Luz del Mundo Faces Court Ruling

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

2026 Data Integration Stars: User Sentiments Revealed

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Banco Macro S.A. Plans $160B Share Buyback Initiative

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Smartpress: Adobe & Canva Shape Print Design World

Adobe's Stranglehold on Professional Design Over at Smartpress, they've pulled the curtain back on just how heavily Adobe Creative Suite weighs in on the print design sector. The company's recent analysis shines a light on the staggering 66% dominance of Adobe's InDesign and Illustrator in file submissions. That's a hefty portion influencing both the quality and financial...

Atlantic Blvd Apartments: A Game-Changer for Housing

A Bold Move for Attainable Housing Amidst the hustle and bustle of Sterling, Virginia, a new player has hit the scene: Atlantic Blvd Apartments. A property designed solely for attainable housing, this development is a showcase of what can be accomplished when local government and private developers team up with a shared vision. It feels like a breath of fresh air in a...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Clip Expands Horizons with Pulpos Acquisition, New Board Member

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Infection Control Market Set for Explosive Growth by 2031

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....